Negligible Effect of Quercetin in the Pharmacokinetics of Sulfasalazine in Rats and Beagles: Metabolic Inactivation of the Interaction Potential of Quercetin with BCRP
Breast cancer resistance protein (BCRP) mediates pharmacokinetic drug interactions. This study evaluated the potential of quercetin to inhibit and induce BCRP in vitro and in vivo. The inhibition of BCRP was investigated for quercetin and its metabolites using BCRP/mBcrp1-overexpressing MDCKII cells...
Main Authors: | Ju-Hee Oh, Dokeun Kim, Haejun Lee, Gyeonghee Kim, Taehoon Park, Min Chang Kim, Young-Joo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/12/1989 |
Similar Items
-
Quercetin Is a Flavonoid Breast Cancer Resistance Protein Inhibitor with an Impact on the Oral Pharmacokinetics of Sulfasalazine in Rats
by: Yoo-Kyung Song, et al.
Published: (2020-04-01) -
In vitro release and cytotoxicity study of encapsulated sulfasalazine within LTSP micellar/liposomal and TSP micellar/niosomal nano-formulations
by: Mohammad Javed Ansari, et al.
Published: (2022-12-01) -
Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine
by: Ju-Suk Nam, et al.
Published: (2016-01-01) -
Bioactivity and Therapeutic Potential of Kaempferol and Quercetin: New Insights for Plant and Human Health
by: Rahmatullah Jan, et al.
Published: (2022-10-01) -
A Micellar Formulation of Quercetin Prevents Cisplatin Nephrotoxicity
by: Alfredo G. Casanova, et al.
Published: (2021-01-01)